Ceptaris Therapeutics, Inc., a privately held, specialty pharmaceutical company, announced that the FDA has granted marketing approval for the orphan...
Actelion Ltd announced that the European Commission has granted marketing authorization for the use of Ledaga (chlormethine gel) 160 micrograms/g...
Nurofen Joint & Muscular Pain Relief 200mg Medicated Plaster is indicated for the short-term symptomatic treatment of local pain in acute muscular strains, or sprains in benign traumas close to the joint of the upper or lower limb in adults or adolescents aged 16 years and older.
Short term treatment (max. 7 days) Local symptomatic and short term treatment of pain in acute strains, sprains or bruises of the extremities following blunt trauma, e.g. sports injuries in adolescents from 16 years of age and adults.
Treatment of mild cases of distal and lateral subungual onychomycoses caused by dermatophytes, yeasts and moulds limited up to 2 nails.
Treatment of mild cases of distal and lateral subungual onychomycoses caused by dermatophytes, yeasts and moulds; treatment is limited to 2 nails.
Local symptomatic treatment of pain in epicondylitis and ankle sprain.
Veru Inc announced that the Phase III COVID-19 study results of VERU 111 (sabizabulin) for the Treatment of Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome (ARDS) were presented at the 11th International Conference on Emerging Infectious Diseases (ICEID) on August 8, 2022